Naloxone Co-prescribing to Patients Receiving Prescription Opioids in the Medicare Part D Program, United States, 2016-2017

JAMA - Journal of the American Medical Association

Volumn 322, Issue 5, 2019, Pages 462-464

  Jones, Christopher M ^a   Compton, Wilson ^b   Vythilingam, Meena ^c   Giroir, Brett ^c  

^a NATIONAL CENTER FOR INJURY PREVENTION AND CONTROL   (United States)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

^c U S DEPARTMENT OF HEALTH AND HUMAN SERVICES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BENZODIAZEPINE DERIVATIVE; NALOXONE; OPIATE; NARCOTIC ANALGESIC AGENT;

DRUG FORMULATION; DRUG OVERDOSE; HOSPICE PATIENT; HUMAN; LETTER; LONG TERM CARE; MAJOR CLINICAL STUDY; MEDICAID; MEDICARE; NEBRASKA; PRESCRIPTION; PRIORITY JOURNAL; PUBLIC HEALTH SERVICE; RISK FACTOR; TREATMENT DURATION; UNITED STATES; VIRGINIA; CLINICAL PRACTICE; COMBINATION DRUG THERAPY; GOVERNMENT REGULATION; STATISTICS AND NUMERICAL DATA;

ANALGESICS, OPIOID; BENZODIAZEPINES; DRUG PRESCRIPTIONS; DRUG THERAPY, COMBINATION; GOVERNMENT REGULATION; HUMANS; MEDICARE PART D; NALOXONE; PRACTICE PATTERNS, PHYSICIANS'; UNITED STATES;

EID: 85070614030     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.2019.7988     Document Type: Letter

References (6)

1. US Department of Health and Human Services. Naloxone: the opioid reversal drug that saves lives-how healthcare providers and patients can better utilize this life-saving drug. https://www.hhs.gov/opioids/sites/default/files/2018-12/naloxone-coprescribing-guidance.pdf. Published 2018. Accessed May 1, 2019.
2. Dowell D, Haegerich TM, Chou R. CDC guideline for prescribing opioids for chronic pain-United States, 2016. JAMA. 2016; 315 (15): 1624-1645. doi: 10.1001/jama.2016.1464 26977696
3. Vermont Department of Health. Rule governing the prescribing of opioids for pain. http://www.healthvermont.gov/sites/default/files/documents/pdf/REG-opioids-prescribing-for-pain.pdf. Published March 2019. Accessed April 28, 2019.
4. Virginia Department of Health Professions, Board of Medicine. Board of Medicine regulations on opioid prescribing and buprenorphine. https://www.dhp.virginia.gov/medicine/newsletters/OpioidPrescribingBuprenorphine03142017.pdf. Published 2017. Accessed April 28, 2019.
5. Centers for Medicare & Medicaid Services. Opioid oral morphine milligram equivalent (MME) conversion factors. https://www.cms.gov/Medicare/Prescription-Drug-Coverage/PrescriptionDrugCovContra/Downloads/Oral-MME-CFs-vFeb-2018.pdf. Accessed May 1, 2019.
6. Oliva EM, Christopher MLD, Wells D,; Veterans Health Administration Opioid Overdose Education and Naloxone Distribution National Support and Development Workgroup. Opioid overdose education and naloxone distribution: development of the Veterans Health Administration's national program. J Am Pharm Assoc (2003). 2017; 57 (2S): S168-S179. doi: 10.1016/j.japh.2017.01.022 28292502